Chiral bis-acetal porphyrazines as near-infrared optical agents for detection and treatment of cancer.
We report the preparation of chiral oxygen atom-appended porphyrazines (pzs) as biomedical optical agents that absorb and emit in the near-IR wavelength range. These pzs take the form M[pz(A(4-n)B(n))], where "A" and "B" represent moieties appended to the pz's pyrrole entities, A = (2R,3R) 2,3-dimethyl-2,3-dimethoxy-1,4-diox-2-ene, B = beta,beta'-di-isopropoxybenzo, M is the incorporated metal ion (M = H(2), Zn), and n = 0, 1, 2 (-cis/-trans) and 3 (Scheme 1). When dissolved in polar media, H(2)[pz(trans-A(2)B(2))] 5a does not fluoresce and has a negligible quantum yield for singlet oxygen generation (capital EF, Cyrillic(Delta) = 0.074 +/- 0.001, methanol), as measured by the photo-oxidation of DMA. However, when sequestered in the nonpolar environment of a liposome, it displays strong NIR emission (lambda(max) = 705 nm, capital EF, Cyrillic(f) = 0.087) and an extremely high singlet oxygen quantum yield (capital EF, Cyrillic(Delta)-->1). Of this series, H(2)[pz(trans-A(2)B(2))] 5a is attractive as a potential optical probe, showing strongly fluorescent uptake by cells in culture, while 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide measurements of cell viability show no evidence of dark toxicity. This agent does show significant photoinduced toxicity suggesting that pzs such as 5a have promise as "theranostic" optical agents that can be visualized with fluorescence imaging while acting as a sensitizer for photodynamic therapy.
Trivedi
Evan R
ER
Department of Chemistry, Northwestern University, Evanston, IL, USA.
Vesper
Benjamin J
BJ
Weitman
Hana
H
Ehrenberg
Benjamin
B
Barrett
Anthony G M
AG
Radosevich
James A
JA
Hoffman
Brian M
BM
D000970:Antineoplastic Agents; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D006801:Humans; D007259:Infrared Rays; D008081:Liposomes / Q000494:pharmacology; D009369:Neoplasms / Q000628:therapy*; D010778:Photochemotherapy / Q000379:methods*; D011166:Porphyrins / Q000138:chemical synthesis* / Q000627:therapeutic use / Q000633:toxicity; D013237:Stereoisomerism
D000970:Antineoplastic Agents; D008081:Liposomes; D011166:Porphyrins